12
views
0
recommends
+1 Recommend
2 collections
    0
    shares

          The flagship journal of the Society for Endocrinology. Learn more

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Impact of placental mTOR deficiency on peripheral insulin signaling in adult mice offspring

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Suboptimal in utero environments such as poor maternal nutrition and gestational diabetes can impact fetal birth weight and the metabolic health trajectory of the adult offspring. Fetal growth is associated with alterations in placental mechanistic target of rapamycin (mTOR) signaling; it is reduced in fetal growth restriction and increased in fetal overgrowth. We previously reported that when metabolically challenged by a high-fat diet, placental mTORKO (mTORKO pl) adult female offspring develop obesity and insulin resistance, whereas placental TSC2KO (TSC2KO pl) female offspring are protected from diet-induced obesity and maintain proper glucose homeostasis. In the present study, we sought to investigate whether reducing or increasing placental mTOR signaling in utero alters the programming of adult offspring metabolic tissues preceding a metabolic challenge. Adult male and female mTORKO pl, TSC2KO pl, and respective controls on a normal chow diet were subjected to an acute intraperitoneal insulin injection. Upon insulin stimulation, insulin signaling via phosphorylation of Akt and nutrient sensing via phosphorylation of mTOR target ribosomal S6 were evaluated in the offspring liver, white adipose tissue, and skeletal muscle. Among tested tissues, we observed significant changes only in the liver signaling. In the male mTORKO pl adult offspring liver, insulin-stimulated phospho-Akt was enhanced compared to littermate controls. Basal phospho-S6 level was increased in the mTORKO pl female offspring liver compared to littermate controls and did not increase further in response to insulin. RNA sequencing of offspring liver identified placental mTORC1 programming-mediated differentially expressed genes. The expression of major urinary protein 1 ( Mup1) was differentially altered in female mTORKO pl and TSC2KO pl offspring livers and we show that MUP1 level is dependent on overnutrition and fasting status. In summary, deletion of placental mTOR nutrient sensing in utero programs hepatic response to insulin action in a sexually dimorphic manner. Additionally, we highlight a possible role for hepatic and circulating MUP1 in glucose homeostasis that warrants further investigation.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: found
          • Article: not found

          Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.

          Deregulation of Akt/protein kinase B (PKB) is implicated in the pathogenesis of cancer and diabetes. Akt/PKB activation requires the phosphorylation of Thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser473 within the carboxyl-terminal hydrophobic motif by an unknown kinase. We show that in Drosophila and human cells the target of rapamycin (TOR) kinase and its associated protein rictor are necessary for Ser473 phosphorylation and that a reduction in rictor or mammalian TOR (mTOR) expression inhibited an Akt/PKB effector. The rictor-mTOR complex directly phosphorylated Akt/PKB on Ser473 in vitro and facilitated Thr308 phosphorylation by PDK1. Rictor-mTOR may serve as a drug target in tumors that have lost the expression of PTEN, a tumor suppressor that opposes Akt/PKB activation.
            • Record: found
            • Abstract: found
            • Article: not found

            Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure

            Loss of functional β-cell mass is the key mechanism leading to the two main forms of diabetes mellitus - type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). Understanding the mechanisms behind β-cell failure is critical to prevent or revert disease. Basic pathogenic differences exist in the two forms of diabetes mellitus; T1DM is immune mediated and T2DM is mediated by metabolic mechanisms. These mechanisms differentially affect early β-cell dysfunction and eventual fate. Over the past decade, major advances have been made in the field, mostly delivered by studies on β-cells in human disease. These advances include studies of islet morphology and human β-cell gene expression in T1DM and T2DM, the identification and characterization of the role of T1DM and T2DM candidate genes at the β-cell level and the endoplasmic reticulum stress signalling that contributes to β-cell failure in T1DM (mostly IRE1 driven) and T2DM (mostly PERK-eIF2α dependent). Here, we review these new findings, focusing on studies performed on human β-cells or on samples obtained from patients with diabetes mellitus.
              • Record: found
              • Abstract: found
              • Article: not found

              Pathogenesis of type 2 diabetes mellitus.

              This article provides an overview of the pathogenesis of type 2 diabetes mellitus. Discussion begins by describing normal glucose homeostasis and ingestion of a typical meal and then discusses glucose homeostasis in diabetes. Topics covered include insulin secretion in type 2 diabetes mellitus and insulin resistance, the site of insulin resistance, the interaction between insulin sensitivity and secretion, the role of adipocytes in the pathogenesis of type 2 diabetes, cellular mechanisms of insulin resistance including glucose transport and phosphorylation, glycogen and synthesis,glucose and oxidation, glycolysis, and insulin signaling.

                Author and article information

                Journal
                J Mol Endocrinol
                J Mol Endocrinol
                JME
                Journal of Molecular Endocrinology
                Bioscientifica Ltd (Bristol )
                0952-5041
                1479-6813
                18 October 2023
                29 September 2023
                01 November 2023
                : 71
                : 4
                : e230035
                Affiliations
                [1 ]Department of Integrative Biology and Physiology , University of Minnesota Medical School, Minneapolis, Minnesota, USA
                [2 ]University of Minnesota Informatics Institute (UMII) , Minneapolis, Minnesota, USA
                Author notes
                Correspondence should be addressed to E Alejandro: ealejand@ 123456umn.edu
                Author information
                http://orcid.org/0000-0002-3820-8611
                http://orcid.org/0000-0002-7941-8439
                Article
                JME-23-0035
                10.1530/JME-23-0035
                10620464
                37855320
                0699da8e-5562-45af-af20-b12f862b1472
                © the author(s)

                This work is licensed under a Creative Commons Attribution 4.0 International License.

                History
                : 20 March 2023
                : 29 September 2023
                Categories
                Research

                Endocrinology & Diabetes
                mtor,insulin sensitivity,diabetes,placenta,fetal programming,mup1
                Endocrinology & Diabetes
                mtor, insulin sensitivity, diabetes, placenta, fetal programming, mup1

                Comments

                Comment on this article

                Related Documents Log